S
Shue Fen Luo
Researcher at Memorial Hospital of South Bend
Publications - 12
Citations - 1279
Shue Fen Luo is an academic researcher from Memorial Hospital of South Bend. The author has contributed to research in topics: Systemic lupus erythematosus & Cross-sectional study. The author has an hindex of 10, co-authored 12 publications receiving 938 citations. Previous affiliations of Shue Fen Luo include Chang Gung University.
Papers
More filters
Journal ArticleDOI
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados,Martin Soubrier,Anna Antunez,Peter V. Balint,Alejandro Balsa,Maya H Buch,Maya H Buch,Gustavo Casado,Jacqueline Detert,Bassel Elzorkany,Paul Emery,Paul Emery,Najia Hajjaj-Hassouni,Masayoshi Harigai,Shue Fen Luo,Reka Kurucz,Gabriel Maciel,Emilio Martin Mola,Carlomaurizio Montecucco,Iain B. McInnes,Helga Radner,Josef S Smolen,Yeong Wook Song,Harald E. Vonkeman,Kevin L. Winthrop,Jonathan Kay +25 more
TL;DR: In this multinational sample of rheumatoid arthritis patients, variability among countries was wide, not only in prevalence but also in compliance with recommendations for preventing and managing these comorbidities.
Journal ArticleDOI
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
Anna Molto,Adrien Etcheto,Désirée van der Heijde,Robert Landewé,Filip Van den Bosch,Wilson Bautista Molano,Rubén Burgos-Vargas,Peter P. Cheung,Eduardo Collantes-Estevez,Atul Deodhar,Bassel Elzorkany,Shandor Erdes,Jieruo Gu,Najia Hajjaj-Hassouni,Uta Kiltz,Tae-Hwan Kim,Mitsumasa Kishimoto,Shue Fen Luo,Pedro Machado,Pedro Machado,Walter P. Maksymowych,José A. Maldonado-Cocco,Helena Marzo-Ortega,Carlomaurizio Montecucco,Salih Ozgocmen,Floris A. van Gaalen,Maxime Dougados +26 more
TL;DR: Rigorous application of systematic evaluation of comorbidities may permit earlier detection of previously unknown risk factors, which may ultimately result in an improved outcome of patients with SpA.
Journal ArticleDOI
2018 update of the APLAR recommendations for treatment of rheumatoid arthritis
Chak Sing Lau,Faith Li-Ann Chia,Leonila F. Dans,Andrew A. Harrison,Tsu-Yi Hsieh,Rahul Jain,Seung Min Jung,Mitsumasa Kishimoto,Ashok Kumar,Khai Pang Leong,Zhanguo Li,Juan Javier Lichauco,Worawit Louthrenoo,Shue Fen Luo,Rong Mu,Peter Nash,Chin Teck Ng,Chin Teck Ng,Bagus Putu Putra Suryana,Linda K Wijaya,Swan Sim Yeap +20 more
TL;DR: To update recommendations based on current best evidence concerning the treatment of rheumatoid arthritis, focusing particularly on the role of targeted therapies, to inform clinicians on new developments that will impact their current practice.
Journal ArticleDOI
Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study
Vera Golder,Rangi Kandane-Rathnayake,Alberta Hoi,Molla Huq,Worawit Louthrenoo,Yuan An,Zhanguo Li,Shue Fen Luo,Sargunan Sockalingam,Chak Sing Lau,Mo Yin Mok,Aisha Lateef,Kate Franklyn,S. Morton,Sandra V. Navarra,Leonid Zamora,Yeong Jian Wu,Laniyati Hamijoyo,Madelynn Chan,Sean O'Neill,Fiona Goldblatt,Mandana Nikpour,Eric F Morand +22 more
TL;DR: Ethnicity, education, disease damage and specific organ involvement impacts HR-QoL in SLE, andainment of LLDAS is associated with better HR- QoL.
Journal ArticleDOI
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
Vera Golder,Rangi Kandane-Rathnayake,Molla Huq,Hieu T. Nim,Worawit Louthrenoo,Shue Fen Luo,Yeong-Jian Jan Wu,Aisha Lateef,Sargunan Sockalingam,Sandra V. Navarra,Leonid Zamora,Laniyati Hamijoyo,Yasuhiro Katsumata,Masayoshi Harigai,Madelynn Chan,Sean O'Neill,Fiona Goldblatt,Fiona Goldblatt,Chak Sing Lau,Zhanguo Li,Alberta Hoi,Mandana Nikpour,Eric F Morand +22 more
TL;DR: LLDAS attainment is associated with significant protection against flare and damage accrual in SLE, and these findings validate LLDAS as an endpoint for clinical studies in S LE.